News
MedImpact offers low cost, unbranded ustekinumab-aekn biosimilar: San Diego, California Wednesday, August 20, 2025, 13:00 Hrs [IST] MedImpact Holdings Inc., the largest independen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback